Fabienne Lesueur

31PUBLICATIONS
382CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer geneticsMolecular targetsRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Nov 20, 2025
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

Daniel R Barnes, Jonathan P Tyrer, Joe Dennis

|Jun 10, 2025
Body Mass Index, IGF1-Related Polymorphisms, and Risk of Familial Breast Cancer in Women with No BRCA1 or BRCA2 Pathogenic Variant.

Barbara Fritsch-Humblet, Yue Jiao, Séverine Eon-Marchais

|Apr 14, 2025
Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair Genes.

Maximiliano Ribeiro-Guerra, Marie-Gabrielle Dondon, Séverine Eon-Marchais

|Mar 12, 2025
Breast tumors from ATM pathogenic variant carriers display a specific genome-wide DNA methylation profile.

Nicolas M Viart, Anne-Laure Renault, Séverine Eon-Marchais

|Apr 13, 2024
Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia-Telangiectasia Mutated Variant Carriers.

Rayan Bensenane, Arnaud Beddok, Fabienne Lesueur

|Oct 06, 2022
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.

Christopher Hakkaart, John F Pearson, Louise Marquart

Pageof 6